A Study of LAM-002A for the Prevention of Progression of COVID-19
COVID-19 Inpatient | COVID-19 Outpatient
What is the purpose of this trial?
This is a clinical trial to evaluate the efficacy of LAM-002A compared to placebo treatment in adults with a confirmed SARS-CoV-2 infection who are receiving standards supportive care in an outpatient setting.
- Ages18 years and older
- Trial withYale University School of Medicine
- Start Date07/20/2020
- End Date03/31/2021
- Last Updated07/15/2021
- Study HIC#2000028522